Pages that link to "Q51934049"
Jump to navigation
Jump to search
The following pages link to Pegylated nanocapsules produced by an organic solvent-free method: Evaluation of their stealth properties. (Q51934049):
Displaying 15 items.
- Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy (Q26780502) (← links)
- Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers (Q27496024) (← links)
- Lipidic nanocapsule drug delivery: neuronal protection for cochlear implant optimization (Q30467283) (← links)
- Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules (Q33491736) (← links)
- Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers (Q33982639) (← links)
- The Rise and Rise of Stealth Nanocarriers for Cancer Therapy: Passive Versus Active Targeting (Q37815479) (← links)
- Nanoparticle-based delivery for the treatment of inner ear disorders (Q37928393) (← links)
- Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery (Q37996097) (← links)
- Developments in the use of nanocapsules in oncology (Q38117157) (← links)
- Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells (Q39428872) (← links)
- Nanocapsules: the weapons for novel drug delivery systems (Q39670581) (← links)
- Core shell methyl methacrylate chitosan nanoparticles: In vitro mucoadhesion and complement activation (Q41877295) (← links)
- Acid-Labile Polyvinylamine Micro- and Nanogel Capsules (Q42534127) (← links)
- Aqueous core nanocapsules: a new solution for encapsulating doxorubicin hydrochloride (Q45112382) (← links)
- Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect (Q49146067) (← links)